OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(4)
Proteomics
(1)
Organisms
Alphavirus
(1)
Betaherpesvirinae
(1)
Brassica oleracea var. oleracea
(1)
Cowpox virus
(1)
Cytomegalovirus
(1)
EFO:0001352
(1)
Filoviridae
(1)
Hepatitis B virus
(1)
Human alphaherpesvirus 1
(1)
Human betaherpesvirus 5
(1)
Human immunodeficiency virus 1
(1)
Human immunodeficiency virus 2
(1)
Influenza A virus
(1)
Influenza C virus
(1)
Japanese encephalitis virus
(1)
Japanese encephalitis virus group
(1)
Lyssavirus rabies
(1)
Monkeypox virus
(1)
Mus musculus
(1)
Nostoc sp. PCC 7120 = FACHB-418
(1)
Oropouche virus
(1)
Orthopoxvirus
(1)
Orthopoxvirus vaccinia
(1)
Rattus
(1)
Rattus norvegicus
(1)
Ruditapes decussatus
(1)
Tick-borne encephalitis virus
(1)
Viruses
(1)
West Nile virus
(1)
root
(1)
Repository
pride
(1)
Technology Type
Chemical cross-linking coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2019
(1)
Release Date
2025
(2)
2024
(2)
Lab affiliation
Protim
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Dystrophin - Human Dystrophin Structural Changes upon Binding to Anionic Membrane Lipids
Mapping of dystrophin-lipid interactions by mass spectrometry
ORGANISM(S):
Homo sapiens (Human)
2019-11-14
|
PXD007716
|
Pride
Click-chemistry
Phosphlipid
Dystrophin
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
Not available
S-EPMC12492304
|
biostudies-literature
Cite
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559
|
biostudies-literature
Cite
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Not available
S-EPMC11187765
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
